197 related articles for article (PubMed ID: 2388690)
1. Fast track for AIDS and cancer drugs.
Gershon D
Nature; 1990 Aug; 346(6286):685. PubMed ID: 2388690
[No Abstract] [Full Text] [Related]
2. The fast track toward new AIDS drugs.
Long K; Long R
Nurse Pract Forum; 1991 Jun; 2(2):80-1. PubMed ID: 1840952
[No Abstract] [Full Text] [Related]
3. Panel recommends changes to expedite approval of cancer, AIDS drugs.
Am J Hosp Pharm; 1990 Nov; 47(11):2410, 2413. PubMed ID: 2278248
[No Abstract] [Full Text] [Related]
4. The fast track: federal agencies and the political demand for AIDS drugs.
Foreman CH
Brookings Rev; 1991; 9(2):30-7. PubMed ID: 10110828
[No Abstract] [Full Text] [Related]
5. FDA launches "new use initiative".
Nat Biotechnol; 1997 May; 15(5):399. PubMed ID: 9131604
[No Abstract] [Full Text] [Related]
6. FDA expands testing of anti-AIDS drugs.
N Y State J Med; 1989 Sep; 89(9):548. PubMed ID: 2552360
[No Abstract] [Full Text] [Related]
7. Executive summary from the final reports of the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS.
Oncology (Williston Park); 1991 Apr; 5(4):16, 18-9. PubMed ID: 1831034
[No Abstract] [Full Text] [Related]
8. Experimental AIDS drug d4T, now available to patients in critical need.
Ann Allergy; 1993 Sep; 71(3):A24. PubMed ID: 8396862
[No Abstract] [Full Text] [Related]
9. [AIDS, intervention studies and pressure from patients].
Danner SA
Ned Tijdschr Geneeskd; 1990 Sep; 134(38):1835-6. PubMed ID: 2215754
[No Abstract] [Full Text] [Related]
10. A faster track for AIDS drugs?
Kosterlitz J
Natl J (Wash); 1989 Jul; 21(30):1931. PubMed ID: 10293944
[No Abstract] [Full Text] [Related]
11. Cancer and AIDS groups push for changes in drug approval process.
Anderson LF
J Natl Cancer Inst; 1989 Jun; 81(11):829-31. PubMed ID: 2724348
[No Abstract] [Full Text] [Related]
12. Zidovudine approved by FDA for treatment of AIDS.
Clin Pharm; 1987 Jun; 6(6):431,435. PubMed ID: 3319360
[No Abstract] [Full Text] [Related]
13. Stavudine made available under parallel track policy.
Clin Pharm; 1993 Jan; 12(1):7. PubMed ID: 8381342
[No Abstract] [Full Text] [Related]
14. New AIDS drug poised to move into development.
Science; 1991 Dec; 254(5039):1715. PubMed ID: 1763318
[No Abstract] [Full Text] [Related]
15. Editorial: time to end the death trials.
James JS
AIDS Treat News; 1996 Aug; (no 252):1-4. PubMed ID: 11363751
[TBL] [Abstract][Full Text] [Related]
16. AIDS drugs in research.
Hosp Pharm; 1990 Jun; 25(6):572-3, 576. PubMed ID: 10104831
[No Abstract] [Full Text] [Related]
17. AIDS fraud, finances, and fringes.
Sampson WI
N Y State J Med; 1993 Feb; 93(2):92-6. PubMed ID: 8455840
[No Abstract] [Full Text] [Related]
18. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
AIDS Treat News; 1995 Oct; (no 233):4-5. PubMed ID: 11363038
[TBL] [Abstract][Full Text] [Related]
19. The development of new cancer drugs: a joint venture in public policy by the National Cancer Institute and Food and Drug Administration.
Crout JR
Cancer Treat Rep; 1982 Sep; 66(9):1705-7. PubMed ID: 6811133
[No Abstract] [Full Text] [Related]
20. [Treatment of neutropenia in HIV infection with hematopoietic growth factors].
Moreno García M; Fernández González F
Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
